Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marin Nishimura

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|November 15, 2017
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal DiseaseMarin Nishimura, Jonathan C Hsu
Cardiac Electrophysiology Clinics|February 6, 2019
Gender-Based Differences in Cardiac Resynchronization Therapy ResponseMarin Nishimura, Ulrika Birgersdotter-Green
European Heart Journal|November 15, 2018
Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fractionMarin Nishimura, Alan S Maisel
Journal of the American College of Cardiology|January 14, 2017
A Cautionary Tone Before Expanded Adoption of the Proposed CHA<sub>2</sub>DS<sub>2</sub>-VASc R ScoreMarin Nishimura, Jonathan C Hsu
JAMA Cardiology|October 4, 2017
Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When Is the Most Clinically Relevant Time to Evaluate?Marin Nishimura, Isac Thomas, Jonathan C Hsu
International Journal of Cardiology|August 20, 2016
Reversal agents for direct oral anticoagulants: A focused reviewBoris Arbit, Marin Nishimura, Jonathan C Hsu
Circulation|December 29, 2018
Letter by Aldaas et al Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study"Omar M Aldaas, Marin Nishimura, Jonathan C Hsu
Molecular Endocrinology (Baltimore, Md.)|March 5, 2011
Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cellsJoseph Godoy, Marin Nishimura, Nicholas J G Webster
JACC. Clinical Electrophysiology|April 20, 2019
Left Atrial Appendage Electrical Isolation as a Target in Atrial FibrillationMarin Nishimura, Florentino Lupercio-Lopez, Jonathan C Hsu
Expert Review of Molecular Diagnostics|September 21, 2019
An update on the use and discovery of prognostic biomarkers in acute decompensated heart failureDouglas Darden, Marin Nishimura, Justin Sharim, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|November 15, 2017
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal DiseaseMarin Nishimura, Jonathan C Hsu
Cardiac Electrophysiology Clinics|February 6, 2019
Gender-Based Differences in Cardiac Resynchronization Therapy ResponseMarin Nishimura, Ulrika Birgersdotter-Green
European Heart Journal|November 15, 2018
Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fractionMarin Nishimura, Alan S Maisel
Journal of the American College of Cardiology|January 14, 2017
A Cautionary Tone Before Expanded Adoption of the Proposed CHA<sub>2</sub>DS<sub>2</sub>-VASc R ScoreMarin Nishimura, Jonathan C Hsu
JAMA Cardiology|October 4, 2017
Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When Is the Most Clinically Relevant Time to Evaluate?Marin Nishimura, Isac Thomas, Jonathan C Hsu
International Journal of Cardiology|August 20, 2016
Reversal agents for direct oral anticoagulants: A focused reviewBoris Arbit, Marin Nishimura, Jonathan C Hsu
Circulation|December 29, 2018
Letter by Aldaas et al Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study"Omar M Aldaas, Marin Nishimura, Jonathan C Hsu
Molecular Endocrinology (Baltimore, Md.)|March 5, 2011
Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LbetaT2 pituitary gonadotrope cellsJoseph Godoy, Marin Nishimura, Nicholas J G Webster
JACC. Clinical Electrophysiology|April 20, 2019
Left Atrial Appendage Electrical Isolation as a Target in Atrial FibrillationMarin Nishimura, Florentino Lupercio-Lopez, Jonathan C Hsu
Expert Review of Molecular Diagnostics|September 21, 2019
An update on the use and discovery of prognostic biomarkers in acute decompensated heart failureDouglas Darden, Marin Nishimura, Justin Sharim, et al.
Pageof 3